Dr Krishna Ella, co-founder of Bharat Biotech, has been awarded the prestigious INSA India fellowship for 2025 for his significant contributions to vaccine technology and biotechnology.

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella. COVID-19 vaccine: Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 ...

Biovet, part of Bharat Biotech, received CDSCO approval for BIOLUMPIVAXIN, a novel LSD vaccine for dairy cattle and buffaloes ...

Bharat Biotech group company Biovet ... world-class vaccine for animal health. Dr. Krishna Ella, founder, Biovet, said “This DIVA marker vaccine is a game-changer for veterinary medicine for disease ...

Bharat Biotech Chairman Krishna Ella on January 4 said that it is unfair to accuse the company of inexperience as it is a global entity with experience in manufacturing vaccines in ...

Biovet, a Bharat Biotech group company ... (IVRI), ensuring it meets the highest global standards, it added. Dr. Krishna Ella, founder of Biovet, said “This DIVA (differentiation of infected ...

Bharat Biotech Chairman and Managing Director Krishna Ella said the vaccine major is in a continuous state of innovation and product development for Covaxin. "The positive neutralization responses ...

conferred its prestigious India fellowship for 2025 upon Dr Krishna Ella, co-founder and executive chairman of Bharat Biotech, which developed India's first indigenously developed Covid-19 vaccine ...